Race for Human Insulin

In 1980, the announcement of a partnership between Genentech and Eli Lilly triggers a race for human insulin. Novo, eager to beat Eli Lilly, modifies pig insulin but faces disappointment when it proves no better than the original. This misstep comes at a crucial time for Novo, impacting their growth and financial decisions.